Tranexamic Acid Tablets By Merit Organics Ltd.

Tranexamic Acid Tablets are an oral antifibrinolytic medicine containing Tranexamic Acid, a synthetic derivative of the amino acid lysine. It works by inhibiting the activation of plasminogen to plasmin, thereby preventing the breakdown of fibrin clots and helping to reduce excessive bleeding.

Tranexamic Acid Tablets are used for the management of bleeding associated with conditions where excessive fibrinolysis occurs, including heavy menstrual bleeding (menorrhagia), surgical bleeding, dental procedures in patients with bleeding disorders, and other hemorrhagic conditions as directed by a healthcare professional.

Typical Strengths

• 
  Tranexamic Acid Tablets 250 mg
  


• 
  Tranexamic Acid Tablets 500 mg
  


• 
  Tranexamic Acid Tablets 650 mg (market-specific)
  

Therapeutic Category

• 
  Antifibrinolytic Agent
  


• 
  Hemostatic Agent
  

Key Features

• 
  Helps reduce excessive blood loss by stabilizing blood clots.
  


• 
  Provides effective control of bleeding caused by increased fibrinolysis.
  


• 
  Suitable for oral administration.
  


• 
  Available in multiple strengths for different therapeutic requirements.
  

Indications

• 
  Heavy menstrual bleeding (menorrhagia).
  


• 
  Bleeding associated with surgical procedures.
  


• 
  Bleeding after dental extraction in patients with bleeding disorders.
  


• 
  Other bleeding conditions associated with excessive fibrinolysis.